Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 101–200 of 1,000
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions
Joshi, S. (2020) · Cancers · doi:10.3390/cancers12082057 · Cited by 96
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
Zhu, S., Luo, Z., Li, X., Han, X., Shi, S., & Zhang, T. (2020) · Journal of Cancer · doi:10.7150/jca.49692 · Cited by 87
Recent advances for cancer detection and treatment by microfluidic technology, review and update
Bargahi, N., Ghasemali, S., Jahandar-Lashaki, S., & Nazari, A. (2022) · Biological Procedures Online · doi:10.1186/s12575-022-00166-y · Cited by 91
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Shah, D. D., Chorawala, M. R., Raghani, N. R., Patel, R., Fareed, M., Kashid, V. A., & Prajapati, B. G. (2025) · Medical Oncology · doi:10.1007/s12032-025-02641-4 · Cited by 101
Mehraj, U., Qayoom, H., & Mir, M. A. (2021) · Breast Cancer · doi:10.1007/s12282-021-01231-2 · Cited by 85
Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment
Tang, L., He, S., Yin, Y., Liu, H., Hu, J., Cheng, J., & Wang, W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111888 · Cited by 85
Multifunctional nanoparticle for cancer therapy
Gao, Y., Wang, K., Zhang, J. C., Duan, X., Sun, Q., & Men, K. (2023) · MedComm · doi:10.1002/mco2.187 · Cited by 98
The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
Ashrafizadeh, M., Farhood, B., Musa, A. E., Taeb, S., & Najafi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106807 · Cited by 81
Fassler, D. J., Abousamra, S., Gupta, R., Chen, C., Zhao, M., Paredes, D., Batool, S. A., Knudsen, B. S., Escobar-Hoyos, L., Shroyer, K. R., et al. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-01003-0 · Cited by 78
Buhrmann, C., Shayan, P., Banik, K., Kunnumakkara, A. B., Kubatka, P., Koklesová, L., & Shakibaei, M. (2020) · Biomedicines · doi:10.3390/biomedicines8080236 · Cited by 80
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
Pasquale, V. D., & Pavone, L. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186588 · Cited by 81
Targeting of the tumor immune microenvironment by metformin
Wu, Z., Zhang, C., & Najafi, M. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00648-w · Cited by 83
Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
Fiore, R. D., Suleiman, S., Drago‐Ferrante, R., Subbannayya, Y., Pentimalli, F., Giordano, A., & Calleja‐Agius, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095167 · Cited by 83
Plant-derived exosomes: a green approach for cancer drug delivery
Madhan, S., Dhar, R., & Devi, A. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02752j · Cited by 84
Nanotheranostics Targeting the Tumor Microenvironment
Roma‐Rodrigues, C., Pombo, I., Raposo, L. R., Pedrosa, P., Fernandes, A. R., & Baptista, P. V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00197 · Cited by 84
Self-citationLin, R., Fogarty, C. E., Ma, B., Li, H., Ni, G., Liu, X., Yuan, J., & Wang, T. (2021) · BMC Genomics · doi:10.1186/s12864-021-07895-6 · Cited by 88
Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
Kalinin, S., Михайловна, М. А., Sharonova, T. V., Sharoyko, V. V., Bunev, A. S., Supuran, C. T., & Krasavin, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413405 · Cited by 84
Liu, X., Feng, M., Hao, X., Gao, Z., Wu, Z., Wang, Y., Du, L., & Wang, C. (2023) · Oncogene · doi:10.1038/s41388-023-02704-8 · Cited by 78
The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers
Kozlova, N., Grossman, J. E., Iwanicki, M. P., & Muranen, T. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.001 · Cited by 73
“The physical and biochemical properties of the TME play a significant role in tumor progression and metastasis [40].”
BackgroundGuo, S., Liu, X., Zhang, J., Huang, Z., Ye, P., Shi, J., Stalin, A., Wu, C., Lu, S., Zhang, F., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107066 · Cited by 87
Multilevel Mechanisms of Cancer Drug Resistance
Roszkowska, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212402 · Cited by 85
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Le Naour, A., Quemerais, C., Hamel, D., Fournié, J.-J., Couderc, B., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 72
Huang, J., & Xiao, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081586 · Cited by 79
Zhou, M., He, X., Mei, C., & Ou, C. (2023) · Biomarker Research · doi:10.1186/s40364-023-00538-w · Cited by 78
Buhrmann, C., Shayan, P., Brockmueller, A., & Shakibaei, M. (2020) · Molecules · doi:10.3390/molecules25184292 · Cited by 73
Imlimthan, S., Moon, E. S., Rathke, H. G., Afshar‐Oromieh, A., Rösch, F., Rominger, A., & Gourni, E. (2021) · Pharmaceuticals · doi:10.3390/ph14101023 · Cited by 80
Pozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 79
Therapeutic Effects of Cold Atmospheric Plasma on Solid Tumor
Min, T., Xie, X., Ren, K., Sun, T., Wang, H., Dang, C., & Zhang, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.884887 · Cited by 76
Lee, H., Sha, D., Foster, N. R., Shi, Q., Alberts, S. R., Smyrk, T. C., & Sinicrope, F. A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.01.011 · Cited by 73
Wan, P. K.-T., Ryan, A. J., & Seymour, L. W. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.015 · Cited by 74
Recent applications of quantitative systems pharmacology and machine learning models across diseases
Aghamiri, S. S., Amin, R., & Helikar, T. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09790-9 · Cited by 71
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 80
Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity
Pan, D., & Jia, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.757024 · Cited by 70
Breaking the mold: 3D cell cultures reshaping the future of cancer research
Cordeiro, S. Z., Oliveira, B. B. P. P., Valente, R., Ferreira, D., Luz, A., Baptista, P. V., & Fernandes, A. R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1507388 · Cited by 76
Self-citationChirivì, M., Maiullari, F., Milan, M., Presutti, D., Cordiglieri, C., Crosti, M., Sarnicola, M. L., Soluri, A., Volpi, M., Święszkowski, W., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115862 · Cited by 75
Gawali, P., Saraswat, A. L., Bhide, S., Gupta, S., & Patel, K. R. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0257 · Cited by 75
Du, Y., Jiang, X. W., Wang, B., Cao, J., Wang, Y., Yu, J., Wang, X., & Liu, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01896-x · Cited by 65
Wang, S., Kong, L., Wang, L., Zhuang, Y., Guo, C., Zhang, Y., Cui, H., Gu, X., Wu, J., & Jiang, C. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03358-y · Cited by 66
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Tian, L.-R., Lin, M., Zhong, H., Cai, Y., Li, B., Xiao, Z., & Shuai, X. (2022) · Biomaterials Science · doi:10.1039/d2bm00650b · Cited by 65
Kilmister, E. J., Koh, S. P., Weth, F. R., Gray, C., & Tan, S. T. (2022) · Biomedicines · doi:10.3390/biomedicines10112988 · Cited by 74
Wang, P., Yang, W., Shen, S., Wu, C., Wen, L., Cheng, Q., Zhang, B., & Wang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04070 · Cited by 61
The Neuroimmune Axis in the Tumor Microenvironment
Shurin, M. R., Shurin, G. V., Zlotnikov, S. B., & Bunimovich, Y. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900828 · Cited by 64
Wang, Y., Chu, Y., Li, K., Zhang, G., Guo, Z., Wu, X., Qiu, C., Li, Y., Wan, X. H., Sui, J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00353 · Cited by 62
A Systematic Review of PET Textural Analysis and Radiomics in Cancer
Piñeiro-Fiel, M., Moscoso, A., Núñez, V. P., Ruibal, Á., Silva‐Rodríguez, J., & Aguiar, P. (2021) · Diagnostics · doi:10.3390/diagnostics11020380 · Cited by 65
Lebre, F., Chatterjee, N., Costa, S. D. F. Z., Gortari, E. F., Lopes, C., Meneses, J., Ortiz, L., Ribeiro, A. R., Vilas‐Boas, V., & Alfaro‐Moreno, E. (2022) · Nanomaterials · doi:10.3390/nano12111810 · Cited by 69
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Zhu, Y., Kang, E., Wilson, M., Basso, T., Chen, E., Yu, Y., & Li, Y.-R. (2022) · Organoids · doi:10.3390/organoids1020012 · Cited by 67
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
Karimi, S., Bakhshali, R., Bolandi, S., Zahed, Z., Zadeh, S. S. M., Zenjanab, M. K., & Jahanban‐Esfahlan, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101626 · Cited by 73
Nearchou, I. P., Gwyther, B. M., Georgiakakis, E. C. T., Gavriel, C. G., Lillard, K., Kajiwara, Y., Ueno, H., Harrison, D. J., & Caie, P. D. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0275-x · Cited by 66
Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells
Russi, S., Verma, H. K., Laurino, S., Mazzone, P., Storto, G., Nardelli, A., Zoppoli, P., Calice, G., Rocca, F. L., Sgambato, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153736 · Cited by 62
Qattan, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238905 · Cited by 60
Zhang, J., Peng, G., Chi, H., Yang, J., Xie, X., Song, G., Tran, L. J., Xia, Z., & Tian, G. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03138-0 · Cited by 65
Sharma, P., & Otto, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.08.022 · Cited by 66
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Ma, C., & Gürkan-Çavusoglu, E. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00397-7 · Cited by 76
Deshmukh, R., Sethi, P., Singh, B., Shiekmydeen, J., Salave, S., Patel, R. J., Ali, N., Rashid, S., Elossaily, G. M., & Kumar, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081076 · Cited by 72
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
Cox, M. C., Mendes, R., Silva, F., Mendes, T. F., Zelaya-Lazo, A., Halwachs, K., Purkal, J. J., Isidro, I. A., Félix, A., Boghaert, E. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97894-0 · Cited by 58
Self-citationJNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation
Tam, S. Y., & Law, H. (2021) · Cancers · doi:10.3390/cancers13092196 · Cited by 65
IL‐33/ST2 as a potential target for tumor immunotherapy
Jiang, W., Lian, J., Yue, Y., & Zhang, Y. (2021) · European Journal of Immunology · doi:10.1002/eji.202149175 · Cited by 61
Neutrophils as potential therapeutic targets for breast cancer
Gong, Y.-T., Zhang, L., Liu, Y., Tang, M., Lin, J.-Y., Chen, X., Chen, Y.-X., Yan, Y., Zhang, W., Jin, J., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106996 · Cited by 61
Qiao, L., Chen, Y., Liang, N., Xie, J. W., Deng, G., Chen, F., Wang, X., Liu, F., Li, Y., & Zhang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.775238 · Cited by 60
Ortíz, R., Quiñonero, F., García-Pinel, B., Fuel, M., Mesas, C., Cabeza, L., Melguizo, C., & Prados, J. C. (2021) · Cancers · doi:10.3390/cancers13092058 · Cited by 64
Li, Y., Zhao, W., Wang, Y., Wang, H., & Liu, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01382-0 · Cited by 61
Recent advances of nanomedicines for liver cancer therapy
Chi, X., Liu, K., Luo, X., Yin, Z., Lin, H., & Gao, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02871d · Cited by 58
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts
Hyun, D. (2020) · Cancers · doi:10.3390/cancers12071822 · Cited by 61
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Aldinucci, D., Borghese, C., & Casagrande, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102416 · Cited by 63
Leveraging Single-Cell Approaches in Cancer Precision Medicine
Nath, A., & Bild, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.007 · Cited by 71
Bispecific Antibodies for Triple Negative Breast Cancer
Dees, S., Ganesan, R., Singh, S., & Grewal, I. S. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.09.004 · Cited by 61
Deng, S., Cheng, D., Wang, J., Gu, J., Xue, Y., Jiang, Z., Qin, L., Mao, F., Cao, Y., & Cai, K. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02863-2 · Cited by 67
Clinical trial design: Past, present, and future in the context of big data and precision medicine
Li, A., & Bergan, R. C. (2020) · Cancer · doi:10.1002/cncr.33205 · Cited by 64
Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer
Li, Y., Chen, Z., Han, J., Ma, X., Zheng, X., & Chen, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.781233 · Cited by 64
Zhang, J., Li, X., & Huang, L. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.006 · Cited by 58
Dietze, R., Hammoud, M. K., Gómez‐Serrano, M., Unger, A., Bieringer, T., Finkernagel, F., Sokòl, A. M., Nist, A., Stiewe, T., Reinartz, S., et al. (2020) · Theranostics · doi:10.7150/thno.52442 · Cited by 57
Kwantwi, L. B., Wang, S., Zhang, W., Peng, W., Cai, Z., Sheng, Y., Han, X., Wang, X., & Wu, Q. (2021) · Bioengineered · doi:10.1080/21655979.2021.1977102 · Cited by 53
Lu, Y., He, W., Huang, X., He, Y., Gou, X., Liu, X., Hu, Z., Xu, W., Rahman, K., Li, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27407-0 · Cited by 60
Stefańska, K., Józkowiak, M., Volponi, A. A., Shibli, J. A., Golkar‐Narenji, A., Antosik, P., Bukowska, D., Piotrowska‐Kempisty, H., Mozdziak, P. E., Dzięgiel, P., et al. (2023) · Cells · doi:10.3390/cells12030356 · Cited by 60
Zubair, H., Khan, M. A., Anand, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.009 · Cited by 62
Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives
Su, Z. Y., Siak, P. Y., Leong, C., & Cheah, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.840467 · Cited by 63
Light Irradiation of Gold Nanoparticles Toward Advanced Cancer Therapeutics
Amendoeira, A. F. P., Rivas‐García, L., Fernandes, A. R., & Baptista, P. V. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900153 · Cited by 56
Self-citationLuan, N., Mu, Y., Mu, J., Chen, Y., Ye, X., Zhou, Q., Xu, M., Deng, Q., Hu, Y., Tang, Z., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.638244 · Cited by 54
Watanabe, K., Shiga, K., Maeda, A., Harata, S., Yanagita, T., Suzuki, T., Ushigome, H., Maeda, Y., Hirokawa, T., Ogawa, R., et al. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5293 · Cited by 56
Chen, X., Yuan, Q., Liu, J., Xia, S., Shi, X., Su, Y., Wang, Z., Li, S., & Shang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985911 · Cited by 68
Gong, P., Wang, F., Hua, Y., Ying, J., Chen, J., & Qiao, Y. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03815-y · Cited by 65
Kavanaugh, W. M. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1699053 · Cited by 57
Wang, J., Wang, C., Li, Y., Li, M., Zhu, T., Shen, Z., Wang, H., Lv, W., Wang, X., Cheng, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.425 · Cited by 57
Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment
Zhang, N., Wang, J., Foiret, J. L., Dai, Z., & Ferrara, K. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113906 · Cited by 53
Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy
Liu, Q., Aminu, B., Roscow, O., & Zhang, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020791 · Cited by 57
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma
Yang, H., Zhao, L., Zhang, Y., & Li, F. (2021) · Cancer Medicine · doi:10.1002/cam4.4117 · Cited by 53
Lai, Z., Wei, T., Li, Q., Wang, X., Zhang, Y., & Zhang, S. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3564 · Cited by 52
The Role of Autophagy in Tumor Immunology—Complex Mechanisms That May Be Explored Therapeutically
de Souza, A. S. C., Gonçalves, L. B., Lepique, A. P., & de Araujo‐Souza, P. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.603661 · Cited by 54
Emerging Role of Extracellular Vesicles and Cellular Communication in Metastasis
Forder, A., Hsing, C.-Y., Trejo, J., & Garnis, C. (2021) · Cells · doi:10.3390/cells10123429 · Cited by 54
Senescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 59
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Liu, C., Li, C., & Liu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1108776 · Cited by 59
Grasso, G., Colella, F., Forciniti, S., Onesto, V., Iuele, H., Siciliano, A. C., Carnevali, F., Chandra, A., Gigli, G., & del Mercato, L. L. (2023) · Nanoscale Advances · doi:10.1039/d3na00218g · Cited by 56
Kang, S. H., Oh, S. Y., Lee, K.-Y., Lee, H., Kim, M.-S., Kwon, T., Kim, J., Lee, S., Choi, S., & Hong, S. (2023) · Theranostics · doi:10.7150/thno.87329 · Cited by 55
The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
Buoncervello, M., Gabriele, L., & Toschi, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174320 · Cited by 53
Yang, R., Fu, S., Li, R., Zhang, L., Xu, Z., Cao, Y., Cui, H., Kang, Y., & Xue, P. (2020) · Theranostics · doi:10.7150/thno.50486 · Cited by 51
Lin, Z., Zou, J., Sui, X., Yao, S., Lin, L., Wang, J., & Zhao, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20858-5 · Cited by 56
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Zhang, C., Liu, F., Zhang, Y., & Song, C. X. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116234 · Cited by 54
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.